Abstract |
While the pharmaceutical industry is facing highly challenging times, the academic drug discovery sector has the potential to contribute meaningfully to the discovery of novel drug targets and to the development of new mode-of-action therapeutics against a range of diseases, including rare and neglected diseases.
|
Authors | Arianna Loregian, Giorgio Palù |
Journal | Trends in microbiology
(Trends Microbiol)
Vol. 21
Issue 6
Pg. 261-4
(Jun 2013)
ISSN: 1878-4380 [Electronic] England |
PMID | 23731493
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Ltd. All rights reserved. |
Topics |
- Academic Medical Centers
(organization & administration)
- Biomedical Research
- Drug Discovery
- Drug Industry
(organization & administration)
- Humans
- Public-Private Sector Partnerships
- Universities
(organization & administration)
|